Exploring the Association Between Elevated Body Mass Index and Barrett's Esophagus: A Systematic Review and Meta-Analysis

Annals of Thoracic Surgery

Volumn 87, Issue 2, 2009, Pages 655-662

  Kamat, Paresh ^a,c   Wen, Sijin ^b   Morris, Jeffrey ^b   Anandasabapathy, Sharmila ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

BARRETT ESOPHAGUS; BODY MASS; DISEASE ASSOCIATION; GASTROESOPHAGEAL REFLUX; HUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

ADULT; AGE DISTRIBUTION; BARRETT ESOPHAGUS; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 58249135670     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.08.003     Document Type: Review

References (42)

1. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 (1997) 212-215
2. Caygill C.P., Johnston D.A., Lopez M., et al. Lifestyle factors and Barrett's esophagus. American Journal of Gastroenterology 97 (2002) 1328-1331
3. Conio M., Cameron A.J., Romero Y., et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 48 (2001) 304-309
4. Prach A.T., MacDonald T.A., Hopwood D.A., and Johnston D.A. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?. Lancet 350 (1997) 933
5. Crew K.D., and Neugut A.I. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31 (2004) 450-464
6. Eloubeidi M.A., and Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol 33 (2001) 306-309
7. Cameron A.J. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus 15 (2002) 106-108
8. Conio M., Filiberti R., Blanchi S., et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 97 (2002) 225-229
9. Williamson W.A., Ellis Jr. F.H., Gibb S.P., et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Int Med 151 (1991) 2212-2216
10. Menke-Pluymers M.B., Schoute N.W., Mulder A.H., Hop W.C., van Blankenstein M., and Tilanus H.W. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 33 (1992) 1454-1458
11. Wakelin D.E., Al-Mutawa T., Wendel C., Green C., Garewal H.S., and Fass R. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 58 (2003) 350-355
12. Locke III G.R., Talley N.J., Fett S.L., Zinsmeister A.R., and Melton III L.J. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106 (1999) 642-649
13. Oliveria S.A., Christos P.J., Talley N.J., and Dannenberg A.J. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med 159 (1999) 1592-1598
14. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 231 (1999) 20-28
15. Nilsson M., Lundegardh G., Carling L., Ye W., and Lagergren J. Body mass and reflux oesophagitis: an oestrogen-dependent association?. Scand J Gastroenterol 37 (2002) 626-630
16. Stene-Larsen G., Weberg R., Froyshov Larsen I., Bjortuft O., Hoel B., and Berstad A. Relationship of overweight to hiatus hernia and reflux oesophagitis. Scand J Gastroenterol 23 (1988) 427-432
17. Labenz J., Jaspersen D., Kulig M., et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 99 (2004) 1652-1656
18. Lagergren J., Bergstrom R., and Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130 (1999) 883-890
19. Wu A.H., Wan P., and Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 12 (2001) 721-732
20. Cheng K.K., Sharp L., McKinney P.A., et al. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 83 (2000) 127-132
21. Gerson L.B., Shetler K., and Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123 (2002) 461-467
22. Bu X., Ma Y., Der R., Demeester T., Bernstein L., and Chandrasoma P.T. Body mass index is associated with Barrett esophagus and cardiac mucosal metaplasia. Dig Dis Sci 51 (2006) 1589-1594
23. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 (2005) 1825-1831
24. Corley D.A., Levin T.R., Habel L.A., and Buffler P.A. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol 101 (2006) 937-944
25. Johansson J., Hakansson H.O., Mellblom L., et al. Risk factors for Barrett's oesophagus: a population-based approach. Scand J Gastroenterol 42 (2007) 148-156
26. Corley D.A., Kubo A., Levin T.R., et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133 (2007) 34-41
27. Gerson L.B., Ullah N., Fass R., Green C., Shetler K., and Singh G. Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease?. Aliment Pharmacol Ther 25 (2007) 1079-1086
28. Stein D.J., El-Serag H.B., Kuczynski J., Kramer J.R., and Sampliner R.E. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther 22 (2005) 1005-1010
29. Veugelers P.J., Porter G.A., Guernsey D.L., and Casson A.G. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Diseases of the Esophagus 19 (2006) 321-328
30. Edelstein Z.R., Farrow D.C., Bronner M.P., Rosen S.N., and Vaughan T.L. Central adiposity and risk of Barrett's esophagus. Gastroenterology 133 (2007) 403-411
31. El-Serag H.B., Kvapil P., Hacken-Bitar J., and Kramer J.R. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 100 (2005) 2151-2156
32. Smith K.J., O'Brien S.M., Smithers B.M., et al. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14 (2005) 2481-2486
33. Cook M.B., Greenwood D.C., Hardie L.J., Wild C.P., and Forman D. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 103 (2008) 292-300
34. Weinsier R.L., Hunter G.R., Gower B.A., Schutz Y., Darnell B.E., and Zuckerman P.A. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr 74 (2001) 631-636
35. Xu H., Barnes G.T., Yang Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830
36. Cannon J.G., Nerad J.L., Poutsiaka D.D., and Dinarello C.A. Measuring circulating cytokines. J Appl Physiol 75 (1993) 1897-1902
37. Somasundar P., Riggs D., Jackson B., Vona-Davis L., and McFadden D.W. Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg 186 (2003) 575-578
38. Somasundar P., Yu A.K., Vona-Davis L., and McFadden D.W. Differential effects of leptin on cancer in vitro. J Surg Res 113 (2003) 50-55
39. Kaaks R., and Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60 (2001) 91-106
40. Gupta K., Krishnaswamy G., Karnad A., and Peiris A.N. Insulin: a novel factor in carcinogenesis. Am J Med Sci 323 (2002) 140-145
41. Furstenberger G., and Senn H.J. Insulin-like growth factors and cancer. Lancet Oncol 3 (2002) 298-302
42. Vaughan T.L., Dong L.M., Blount P.L., et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 6 (2005) 945-952